Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms [NA]

View source ↗

Summary

A clinical study is evaluating the safety and efficacy of FloStent for men with benign prostatic hyperplasia; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• FloStent

Snippet

Sponsor: Rivermark Medical | Conditions: Benign Prostatic Hyperplasia | NA | Status: RECRUITING